(Q37922395)

25 August 2017

title

Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer (English)

1 reference

adaptive radiation therapy

25 August 2017

main subject

0 references

1 reference

Manoj V Rao

1

1 reference

25 August 2017

Chandy Ellimoottil

2

1 reference

25 August 2017

Timothy Sondej

3

1 reference

25 August 2017

Robert C Flanigan

4

1 reference

25 August 2017

Marcus L Quek

5

1 reference

25 August 2017

publication date

24 August 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

31

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

857-861

1 reference

25 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Cancer incidence after localized therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

The treated natural history of high risk superficial bladder cancer: 15-year outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Urothelial carcinoma after external beam radiation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Radical cystectomy for bladder cancer after definitive prostate cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Complications after cystectomy and urinary diversion in patients previously treated for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Radiation induced late damage to the barrier function of small blood vessels in mouse bladder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Longitudinal Cytokine Expression during IMRT for Prostate Cancer and Acute Treatment Toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Intravesical bacille Calmette-Guérin in the treatment of carcinoma in situ or high-grade superficial bladder carcinoma after radiotherapy for bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

Intravesical bacillus Calmette-Guerin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2011.07.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2011.07.005

1 reference

25 August 2017

1 reference